Nanobiotix | |
Stock Exchange | Euronext Paris |
EPS |
EUR1.54 |
Market Cap |
EUR221.43 M |
Shares Outstanding |
22.2 M |
Public Float |
18.96 M |
Address |
60, rue de Wattignies Paris Ile-de-France 75012 France |
Employees | - |
Website | http://www.nanobiotix.com |
Updated | 07/08/2019 |
Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer. |